Lanean...
Recent updates in the discovery and development of novel antimalarial drug candidates
Though morbidity and mortality due to malaria have declined in the last 15 years, emerging resistance to first-line artemisinin-based antimalarials, absence of efficacious vaccines and limited chemotherapeutic alternatives imperil the consolidation of these gains. As a blueprint to steer future desi...
Gorde:
| Argitaratua izan da: | Medchemcomm |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Royal Society of Chemistry
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6071755/ https://ncbi.nlm.nih.gov/pubmed/30108934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c7md00637c |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|